Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
55 Cards in this Set
- Front
- Back
Common areas of Staph aureus
|
anterior nares, skin, pharyngeal cavity, GI tract
(generally hairy, mucosal areas) |
|
Most predictive variable for invasive disease
|
nasal colonization
|
|
3 classes of colonized patients
|
persistent (same and keeps)
Intermittent Non-carriers |
|
Most common location for staph aureus
|
skin
|
|
Infected pilosebaceous unit, can also get apocrine glands
|
folliculitis (will remain after popping)
|
|
Boil, folliculitis that gets into subQ layer
|
furuncle
|
|
Coalescing furuncles; closest to blood supply
|
carbuncle (warm compress and drainage)
|
|
Which superficial skin infection should be treated with antibiotics?
|
Carbuncles, close to vasculature
|
|
2 main forms of impetigo
|
non-bullous (honey coated)
bullous (almost completely by staph aureus) |
|
2 Key signs for bullous impetigo
|
yellow pus
Nikolsky's skin (rubbing off separate layers) |
|
Systemic sloughing off of skin after staph aureus infection
|
Staph Scalded Skin Syndrome aka pemphigus neonatorum (Ritter's)
|
|
Target of exfoliative toxins in SSSS
|
Desmoglein I (other desmogleins assist as you move further down deeper)
|
|
10% of breastfeeding mothers have this infection
|
mastitis
|
|
superficial cellulitis, "peau d'orange" appearance
|
erysipelas (mild cellulitis)
|
|
Deeper infection, lacks erysipelas presentation, more painful than erisypelas
|
cellulitis
|
|
Acute febrile illness, hypotensive, organ dysfunction, epithelial desquamation
|
S. aureus Toxic Shock Syndrome
(needs iron availability) |
|
Underlying cause of Toxic Shock Syndrome
|
presense of TSST-1 superantigen
bypasses T-cell: antigen specificity, activating up to 20% of T-cell population W/ massive cytokine response |
|
Toxins causing Bullous impetigo/Scalded skin syndrome
|
exfoliative toxins (Eta, Etb)
|
|
3 components of S. aureus bacteremia needed for survival
|
capsule
antimicrobial peptide resistance survival within neutrophil (key to danger) |
|
Colonization of heart valves, chamber septae, and/or vessel walls; Binds to damage mediated by FnbAB and/or ClfAB
|
infective endocarditis
|
|
Symptoms of endocarditis
|
fever w/ hear murmur
petuchiae (in eyes) splenomegaly |
|
Which sided endocarditis is more common in IV drug users?
|
right-sided (knicks tricuspid valve, leading to pulmonary emboli
|
|
Which sided endocarditis is more difficult to treat?
|
Left sided
|
|
Necrotizing pneumonia is often partnered with what?
|
Influenza (70% of superinfections caused by S. aureus)
-PVL also common |
|
Differences in small colony varients
|
slow growing, no gold sheen, not B-hemolytic
-tolerant of antibiotics |
|
2 common presentations of S. aureus small colony variants
|
osteomyelitis (live intracellularly)
pneumonia/cystic fibrosis |
|
Common bones for osteomyelitis
|
long bones in children
vertebrae in adults |
|
septic arthritis
|
S. aureus most common cause in children, non-gonococcal septic arthiritis
|
|
alpha toxin role for staph aureus
|
pore-forming, causes B-hemolysis
|
|
Key for gamma toxin variant, selective for human PMNs
|
Panton-Valentine leukocidin
|
|
Role of delta toxin
|
pore forming
|
|
Why so many toxins?
|
Maintain separation of immune cells and staph aureus
|
|
General type of staph aureus infections
|
extracellular, produce lots of
|
|
Role of MSCRAMMs
|
Adherence
|
|
Role of Protein A, spa
|
binds Fc portion of IgG/B cell receptor
|
|
Porphyrin acquisition use in staph aureus
|
iron/nutrients
|
|
S. aureus innate immune response evasions
|
inhibits opsonophagocytosis (blocks complement activation)
resists PMN killing (resists peptides) |
|
How are surface structures on Staph anchored?
|
sortase
|
|
Location of problems within staph aureus
|
pathogenecity islands (probably moved by phages)
|
|
3 families of S. aureus plasmids
|
rolling circle family
pSK639 family multiresistance family |
|
Alternative transpeptidase gene
|
mecA (from chickens)
|
|
In general, where did community MRSA develop? Which key one did not?
|
Generally in the community, except for USA300 which is one of the most common forms now in both hospital and community
|
|
Common presentation of CA-MRSA
|
skin and soft tissue
|
|
Tx for CA-MRSA
|
trimethoprim-sulfonamide
clindamycin (can have inducible resistance) Vancomycin |
|
What should not be used with a positive D-test?
|
clindamycin
|
|
Key differentiating test for staph
|
positive coagulase test
|
|
Normal cause of non-bullous impetigo
|
GAS, increasingly by s. aureus
|
|
cause of staph food poisoning
|
emetic toxins (SEA-SEU), T-cell over-activation
|
|
Acute infection, usually painless;
lots of swelling in hip, shoulder, knee, or elbow |
Bursitis
|
|
3 purposes of Toxins/hemolysins: HIa, HIb, HIg PVL, HId PSMs
|
cytotoxic to leukocytes/erythrocytes
phagocyte avoidance nutrient release |
|
Purpose of immunomodulation
|
Spa surface structures
|
|
Isd surface structure purpose
|
Fe2+ acquisition
|
|
What do CHIPS, SCIN, SAK do for S. aureus?
|
resist opsonophagocytosis
|
|
What do Dlt and Mpr protect against?
|
antimicrobial peptides
|
|
Purpose of carotenoid pigment
|
antioxidant
|